(Q46289579)

21 December 2017

title

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. (English)

1 reference

21 December 2017

idiopathic pulmonary fibrosis

1 reference

1 reference

Ganesh Raghu

1

1 reference

21 December 2017

Shih-Yin Chen

2

1 reference

21 December 2017

Wei-Shi Yeh

3

1 reference

21 December 2017

Brad Maroni

4

1 reference

21 December 2017

Qian Li

5

1 reference

21 December 2017

Yuan-Chi Lee

6

1 reference

21 December 2017

Harold R Collard

7

1 reference

21 December 2017

publication date

27 May 2014

1 reference

21 December 2017

The Lancet. Respiratory medicine

published in

1 reference

21 December 2017

volume

2

1 reference

21 December 2017

issue

7

1 reference

21 December 2017

page(s)

566-572

1 reference

21 December 2017

Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

The clinical course of patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

The epidemiology of interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Incidence and prevalence of idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Idiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological data

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

The rising incidence of idiopathic pulmonary fibrosis in the U.K

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Idiopathic pulmonary fibrosis--results from a Japanese nationwide epidemiological survey using individual clinical records

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

A multidimensional index and staging system for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Determinants of survival in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Idiopathic pulmonary fibrosis: predicting response to therapy and survival

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970101-8

7 January 2021

10.1016/S2213-2600(14)70101-8

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017